Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTb032250475Recruiting
Open-label, single-arm trial in Salivary gland atrophy and xerostomia, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Evaluation of adverse events. Started Nov 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTb032250475.